[Chronic kidney disease: screening attitude and practice in the absence of randomized controlled trials].
Given the increasing prevalence of chronic kidney disease (CKD), early detection has been proposed. Some organizations recommend CKD screening. Yet, the efficacy of CKD screening is unknown given the absence of randomized controlled trial conducted so far. While CKD screening tests (e.g., glomerular filtration rate) are simple and inexpensive, CKD screening can only be justified if it reduces CKD-related mortality and/or CKD-related morbidity compared to no screening. In addition, CKD screening must provide more benefits than risks to the participants and must be cost-effective. Based on observational studies and cost-effectiveness models, CKD screening has to be proposed to high risk population (patients with hypertension and/or diabetes) but not to the general population.
Ponte
Belén
B
Département de médecine interne, HUG, 1211 Genève 14. belen.ponte@hcuge.ch
Martin
Pierre-Yves
PY
Pechère
Antoinette
A
Burnier
Michel
M
Guessous
Idris
I
D002908:Chronic Disease; D006801:Humans; D007674:Kidney Diseases / Q000145:classification / Q000175:diagnosis*; D008403:Mass Screening; D012307:Risk Factors